AI-generated summary
The authors studied low-level laser therapy in a mouse tail lymphedema model, comparing a laser group, a sham group and a surgical control group with 10 mice each. They report that laser treatment was associated with reduced tail thickness at 10 and 12 days, less inflammation and increased new lymphatic vessel growth, along with higher VEGFR3 expression. The study used a small animal model, so the findings may not apply to humans.
- Who or what was studied
- Six-week-old female mice in an experimental tail lymphedema model (10 mice per group, three groups)
- Limits stated in the abstract
- Animal study with small groups; the abstract does not report wavelength, power or dose of the laser.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Sham, Control group, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.